Center-Authored Papers

Filters: Author is Kumarasamy, Nagalingeswaran  [Clear All Filters]
2011
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JHS et al..  2011.  Prevention of HIV-1 infection with early antiretroviral therapy.. The New England journal of medicine. 365(6):493-505. Abstract
Eshleman SH, Hudelson SE, Redd AD, Wang L, Debes R, Chen YQ, Martens CA, Ricklefs SM, Selig EJ, Porcella SF et al..  2011.  Analysis of Genetic Linkage of HIV From Couples Enrolled in the HIV Prevention Trials Network 052 Trial.. The Journal of infectious diseases. 204 (12):1918-1926. Abstract
2013
Fogel JM, Wang L, Parsons TL, Ou S-S, Piwowar-Manning E, Chen Y, Mudhune VO, Hosseinipour MC, Kumwenda J, Hakim JG et al..  2013.  Undisclosed antiretroviral drug use in a multi-national clinical trial (HPTN 052).. The Journal of infectious diseases. 208(10):1624-8. Abstract
Walensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Paltiel DA, Nakamura YM, Godbole SV, Panchia R, Sanne I et al..  2013.  Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.. The New England journal of medicine. 369(18):1715-25. Abstract
2015
Safren SA, Mayer KH, Ou S-S, McCauley M, Grinsztejn B, Hosseinipour MC, Kumarasamy N, Gamble T, Hoffman I, Celentano D et al..  2015.  Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples.. Journal of acquired immune deficiency syndromes (1999). 69(2):234-40. Abstract
2016
Eshleman SH, Hudelson SE, Redd AD, Swanstrom R, Ou S-S, Zhang XC, Ping L-H, Piwowar-Manning E, Porcella SF, Sievers MF et al..  2016.  Treatment as Prevention: Characterization of partner infections in the HIV Prevention Trials Network 052 trial.. Journal of acquired immune deficiency syndromes (1999). Abstract
Fogel JM, Hudelson SE, Ou S-S, Hart S, Wallis C, Morgado MG, Saravanan S, Tripathy S, Hovind L, Piwowar-Manning E et al..  2016.  Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial.. Journal of acquired immune deficiency syndromes (1999). 72(3):304-309. Abstract
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JHS et al..  2016.  Antiretroviral Therapy for the Prevention of HIV-1 Transmission.. The New England journal of medicine. 375(9):830-9. Abstract
2017
Palumbo PJ, Wilson EA, Piwowar-Manning E, McCauley M, Gamble T, Kumwenda N, Makhema J, Kumarasamy N, Chariyalertsak S, Hakim JG et al..  2017.  Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052.. PloS one. 12(5):e0177281. Abstract
Eshleman SH, Wilson EA, Zhang XC, Ou S-S, Piwowar-Manning E, Eron JJ, McCauley M, Gamble T, Gallant JE, Hosseinipour MC et al..  2017.  Virologic outcomes in early antiretroviral treatment: HPTN 052.. HIV clinical trials. :1-10. Abstract
Greer AE, Ou S-S, Wilson E, Piwowar-Manning E, Forman MS, McCauley M, Gamble T, Ruangyuttikarn C, Hosseinipour MC, Kumarasamy N et al..  2017.  A Comparison of Hepatitis B Virus Infection in HIV-infected and HIV-uninfected Participants Enrolled in a Multi-National Clinical Trial: HPTN 052.. Journal of acquired immune deficiency syndromes (1999). Abstract